临床试验/CTRI/2020/02/023267

CTRI/2020/02/023267尚未招募未知

An Open Label and Single dose Pharmacokinetic Study for the assessment of Berberine in Manasamitra Vatakam, an Ayurvedic Herbo Mineral Formulation.

SRM Institute of Science and Technology0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

阶段: 未知
状态: 尚未招募
发起方: SRM Institute of Science and Technology

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

入选标准

•Willingness to provide written informed consent to participate in the study.
•Volunteers understanding the nature and purpose of the study and who are willing to comply with study procedures.
•Non-smokers or individuals who smoke less than 5 cigarettes per day.
•Teetotalers.Healthy individuals as evaluated by personal history, medical history and general clinical examination

排除标准

•History suggestive of cardiac, gastrointestinal, respiratory, hepatic, renal, endocrine, neurological, metabolic, psychiatric or hematological systems, judged to be clinically significant.
•Subject with clinically significant abnormal values of laboratory parameters.History of diabetes mellitus, tuberculosis and systemic hypertension.
•Subject who had participated in any other clinical study during the last 3 months.

研究者

发起方

SRM Institute of Science and Technology

相似试验

Bio availability study of Mangiferin from polyherbal formulatio

CTRI/2014/01/004271SRM University10

进行中（未招募）

An open label, single dose, pharmacokinetic study of oromucosal midazolam administered to children from 3 months to less than 18 years undergoing routine elective surgery - Midazolam PKIn the context of the trial, the IMP is to be used as anaesthetic premedication in children undergoing elective routine surgery.(The medical condition for marketing is acute seizures in children aged 3 months - <18 years.)MedDRA version: 9.1Level: LLTClassification code 10058073Term: Anaesthetic premedication

EUCTR2009-012808-11-DETherakind Limited75

进行中（未招募）

Study of PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Male Chinese Subjects With Hemophilia AHemophilia A

EUCTR2015-003685-88-Outside-EU/EEAPfizer Inc.13

进行中（未招募）

A single dose study of BeneFIX (nonacog alfa, recombinant factor IX) in male Chinese subjects with haemophilia B.

EUCTR2015-003027-61-Outside-EU/EEAPfizer Inc.12

进行中（未招募）

Investigation of the blood levels at a reduced dose of erlotinib with the addition of ritonavir compared to the normal dose of erlotinib

EUCTR2018-004854-12-NLStichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis10